SHMT1 and lymphangioma: Moreover, high expression of SHMT1 in LM samples was demonstrated to significantly associate with poor OS rate and progression‐free survival (PFS) rate in our independent validation cohort (Figure 3C, n = 87), and the detailed information was enclosed in Table S1 (Supporting Information).